Our research in Liverpool
Liverpool is the home of one of our Cancer Research UK Centres. Bringing together Cancer Research UK scientists with other researchers and medical staff in the city, the Centre is focusing on pancreatic, head and neck, and blood cancers. Researchers are also pioneering the latest techniques in surgery, radiotherapy and the treatment of children's cancers. Find out more about the Liverpool Cancer Research UK Centre.
Our Children's Cancer Trials Team co-ordinates groundbreaking trials in 21 centres across the UK and Ireland, including Alder Hey Children's Hospital in Liverpool. These trials bring cutting-edge science from the lab to the bedside, making innovative new treatments available to children with cancer.
Below are some of the highlights of our research in Liverpool, or you can find out more in our Liverpool leaflet (pdf download).
Click on the names below to find out more about each scientist
These pages contain highlights of the research we fund in this city - we'll be updating and expanding them regularly. Please visit our Funding & Research website for detailed scientific information about our research.
On this page
Eye cancer
Dr Sarah Coupland
Pathology Department
University of Liverpool, Liverpool
Understanding melanoma of the eye
Dr Sarah Coupland specialises in uveal melanoma – a rare type of cancer that starts in the eye. She and her team at the University of Liverpool are investigating the gene faults that can lead to uveal melanoma, with the aim of developing more effective treatments in the future.
Head and neck cancer
Mr Richard Shaw
Division of Surgical Oncology
University of Liverpool, Liverpool
Improving treatment for head and neck cancers
Richard Shaw is a surgeon specialising in the treatment of head and neck cancers. He's running a number of important clinical trials aiming to improve the way that these diseases are treated.
Kidney cancer
Professor Michael Clague
Cell Signalling Laboratory
University of Liverpool, Liverpool
Understanding the genes behind kidney cancer
Professor Michael Clague is based at the Cell Signalling Laboratory at the University of Liverpool. He is investigating changes in cells caused by an inherited condition called Von Hippel-Lindau syndrome, which can lead to kidney cancer. His work is aimed at identifying new ways to treat kidney cancer, helping more people to survive the disease.
Leukaemia
Professor Andrew Pettitt
Department of Haematology, School of Cancer Studies
University of Liverpool, Liverpool
Improving treatment for lymphoma
Professor Andrew Pettitt is a leading expert on leukaemia and lymphoma at the University of Liverpool. He is researching ways to improve treatments for these diseases, and is part of the Liverpool Cancer Research UK Centre.
Lymphoma
Professor Andrew Pettitt
Department of Haematology, School of Cancer Studies
University of Liverpool, Liverpool
Improving treatment for lymphoma
Professor Andrew Pettitt is a leading expert on leukaemia and lymphoma at the University of Liverpool. He is researching ways to improve treatments for these diseases, and is part of the Liverpool Cancer Research UK Centre.
No specific cancer type
Professor Francis Barr
Cell Growth and Division Group
Cancer Research Centre, University of Liverpool, Liverpool
Splitting up - understanding how cancer cells divide
Professor Francis Barr heads the Cell Growth and Division Group at the University of Liverpool. He is studying how cells divide to make new cells, focusing on the last step in the process of cell division, in which a single cell finally splits to create two ‘daughter’ cells. This is called cytokinesis.
Oesophageal cancer
Dr Janet Risk
School of Dental Sciences
University of Liverpool, Liverpool
Understanding the genetic causes of oesophageal cancer
Dr Janet Risk, based at the University of Liverpool, is finding out how a molecule called cytoglobin is involved in oesophageal cancer. She’s carrying out innovative experiments on cells in the lab to understand how different amounts of cytoglobin affect the growth and spread of this disease.
Pancreatic cancer
Prof John Neoptolemos
Division of Surgery and Oncology
University of Liverpool, Liverpool
Better treatments for pancreatic cancer
Professor John Neoptolemos is Head of the Division of Surgery and Oncology at the University of Liverpool. He combines his clinical work with lab-based research and also runs the Clinical Trials Unit at the Royal Liverpool University Hospital. Professor Neoptolemos is an international expert in the treatment of pancreatic cancer and is researching how survival can be improved for people with this disease.
- Share this: Tweet
-
-
- Print this page
-
Email this page
Increase text
Decrease text
Print this page
